Thursday, November 12, 2026

Live

Novel CRISPR therapy is poised to gain first FDA approval to alter genes inside the body What Jensen Huang’s resignation means for Nvidia, global AI race What to know after Hegseth awards medal to soldier who reprimanded group at Arlington USPS adds permanent postage surcharge, citing higher fuel costs Poland says Pentagon has ‘greenlit’ permanent US base Congress isn’t letting Nvidia’s Huang off the hookNovel CRISPR therapy is poised to gain first FDA approval to alter genes inside the body What Jensen Huang’s resignation means for Nvidia, global AI race What to know after Hegseth awards medal to soldier who reprimanded group at Arlington USPS adds permanent postage surcharge, citing higher fuel costs Poland says Pentagon has ‘greenlit’ permanent US base Congress isn’t letting Nvidia’s Huang off the hook

77,189 Ledger Records as of 23:33 UTC95 added in the last hour1,658 in the last 24 hours

What is counted?

Counted at 23:33:14 UTC. These figures count ledger entries that have a record hash, the same entries as the total. The newest of them was added at 23:33:03 UTC on 2026-11-12. Entries are added in batches when MAP checks its feeds, so the figures vary through the day.

Healthcare

Novel CRISPR therapy is poised to gain first FDA approval to alter genes inside the body

By Heidi Ledford Nature November 12, 2026

Feed excerpt — reported by Nature

Nature, Published online: 12 November 2026; doi:10.1038/d41586-026-03705-9Earlier CRISPR treatments require removal of a participant’s cells, a complex and costly approach.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Nature →

Powered by